Document Detail


Elevated serum CA 125 levels in mitral stenotic patients with heart failure.
MedLine Citation:
PMID:  12975539     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Elevated tumor marker levels have been reported in heart failure patients with left ventricular (LV) systolic dysfunction and enlargement. The levels of several tumor markers, including CA 125, CA 19-9, CA 15-3 and CEA, in rheumatic mitral stenotic patients were compared to the control group. MATERIALS AND METHODS: Tumor markers were measured in 60 mitral stenotic patients and in 30 normal subjects who served as the control group. Mitral stenotic patients were classified into two categories of cardiac dysfunction based on the classification of the New York Heart Association (NYHA). Group I consisted of 31 patients in NYHA class 3-4 and group II of 29 patients in NYHA class 1-2. Echocardiographic examinations and invasive hemodynamic monitoring were performed in all patients. RESULTS: Group I patients had decreased mitral valve area (p = 0.004) and higher left atrial diameter (p = 0.003) than group II patients. Right atrial, mean pulmonary artery and pulmonary capillary wedge pressures and transmitral gradient were higher in group I than in group II (p = 0.010, 0.0001, 0.0001 and 0.0001, respectively). CA 125 levels were statistically higher in mitral stenotic patient groups than in the control group (p < 0.0001). No statistically significant differences were shown for the other tumor markers. Group I patients had higher CA 125 levels compared to group II (p < 0.0001). CONCLUSION: Elevated CA 125 levels may be due to venous congestion and activation of peritoneal mesothelium or increased signal peptides.
Authors:
Can Duman; Ertugrul Ercan; Istemihan Tengiz; Huseyin Bozdemir; H Ekin Ercan; Istemi Nalbantgil
Related Documents :
19028479 - Relationship between activin a level and infarct size in patients with acute myocardial...
21346369 - Occurrence of nonceliac gluten sensitivity in patients with allergic disease.
9350939 - Cardiac troponin t in patients with clinically suspected myocarditis.
7508259 - The impact of prostatic manipulation upon serum psa in patients with adenocarcinoma of ...
8775319 - Immunological and genetic studies on hereditary angioedema.
18258649 - Biochemical markers of myocardial injury in the pericardial fluid of patients undergoin...
4048389 - Microscopic polyarteritis: presentation, pathology and prognosis.
14997019 - Analysis of il-1alpha, il-1beta, and il-1ra [correction of il-ra] polymorphisms in dyst...
10534939 - Pulmonary sarcoidosis in a south indian hospital: clinical and lung function profile.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiology     Volume:  100     ISSN:  0008-6312     ISO Abbreviation:  Cardiology     Publication Date:  2003  
Date Detail:
Created Date:  2003-09-16     Completed Date:  2004-01-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  1266406     Medline TA:  Cardiology     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  7-10     Citation Subset:  IM    
Copyright Information:
Copyright 2003 S. Karger AG, Basel
Affiliation:
Department of Biochemistry, Kocaeli University, Kocaeli, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
CA-125 Antigen / blood*
Cardiac Output, Low / blood*,  complications,  ultrasonography
Case-Control Studies
Female
Humans
Male
Middle Aged
Mitral Valve Stenosis / blood*,  complications,  ultrasonography
Prospective Studies
Risk Factors
Tumor Markers, Biological / blood*
Chemical
Reg. No./Substance:
0/CA-125 Antigen; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  C-reactive protein levels and arterial abnormalities in the offspring of patients with premature myo...
Next Document:  Does chronic ST segment elevation following Q wave myocardial infarction exclude tissue viability?